These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L. Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873 [Abstract] [Full Text] [Related]
3. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J. Blood; 2001 Jan 15; 97(2):376-82. PubMed ID: 11154211 [Abstract] [Full Text] [Related]
4. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib. Ishiguro A, Nakahata T, Shimbo T, Amano Y, Yasui K, Koike K, Komiyama A. Eur J Pediatr; 1993 Jan 15; 152(1):18-20. PubMed ID: 7680314 [Abstract] [Full Text] [Related]
5. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test. Turki A, Stockler S, Sirrs S, Duddy K, Ho G, Elango R. Mol Genet Metab Rep; 2023 Mar 15; 34():100955. PubMed ID: 36632325 [Abstract] [Full Text] [Related]
9. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Lesma E, Riva E, Giovannini M, Di Giulio AM, Gorio A. Int J Immunopathol Pharmacol; 2005 Nov 15; 18(2):297-307. PubMed ID: 15888252 [Abstract] [Full Text] [Related]
11. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1. Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Groenier KH, Smit GP. Eur J Pediatr; 2002 Oct 15; 161 Suppl 1():S83-7. PubMed ID: 12373578 [Abstract] [Full Text] [Related]
13. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration. Kim GY, Lee YM, Kwon JH, Jun HS, Chou J. Biochem Biophys Res Commun; 2017 Jan 22; 482(4):569-574. PubMed ID: 27864142 [Abstract] [Full Text] [Related]
15. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K. Am J Hematol; 2003 Feb 22; 72(2):82-93. PubMed ID: 12555210 [Abstract] [Full Text] [Related]
16. Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib. Sarajlija A, Djordjevic M, Kecman B, Skakic A, Pavlovic S, Pasic S, Stojiljkovic M. Eur J Med Genet; 2020 Mar 22; 63(3):103767. PubMed ID: 31536830 [Abstract] [Full Text] [Related]
17. Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b. Grünert SC, Gautschi M, Baker J, Boyer M, Burlina A, Casswall T, Corpeleijn W, Çıki K, Cotter M, Crushell E, Derks TGJ, Haas D, Kilavuz S, Kingma SDK, Korman SH, Kozek A, de Laet C, Mundy H, Nassogne MC, Quintero V, Rossi A, Spenger J, Spiegel R, Stephenne X, Stojkov D, Tal G, Veiga-da Cunha M, Wortmann SB. Mol Genet Metab; 2024 Jun 22; 142(2):108486. PubMed ID: 38733639 [Abstract] [Full Text] [Related]